HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jean Leandro Dos Santos Selected Research

methyl nitrate

4/2011Assessment of the in vivo genotoxicity of new lead compounds to treat sickle cell disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jean Leandro Dos Santos Research Topics

Disease

8Sickle Cell Anemia (Hemoglobin S Disease)
01/2022 - 04/2011
4Neoplasms (Cancer)
01/2021 - 11/2016
3Chagas Disease (American Trypanosomiasis)
05/2022 - 07/2018
3Malaria
01/2019 - 01/2014
2Extensively Drug-Resistant Tuberculosis
01/2022 - 06/2017
2Skin Neoplasms (Skin Cancer)
12/2019 - 05/2014
2Communicable Diseases (Infectious Diseases)
01/2019 - 01/2018
2Tuberculosis (Tuberculoses)
01/2018 - 11/2016
2Latent Tuberculosis
06/2017 - 01/2015
1Cardiomyopathies (Cardiomyopathy)
05/2022
1Esophageal Achalasia (Megaesophagus)
05/2022
1Megacolon
05/2022
1Priapism
01/2022
1Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2020
1Atopic Dermatitis (Atopic Eczema)
10/2019
1Multiple Myeloma
10/2019
1Leishmaniasis
01/2019
1African Trypanosomiasis (Nagana)
01/2019
1Neglected Diseases
01/2018
1Cardiovascular Diseases (Cardiovascular Disease)
11/2017
1Neurodegenerative Diseases (Neurodegenerative Disease)
11/2017
1Infections
10/2015
1Vivax Malaria
01/2014
1Hepatocellular Carcinoma (Hepatoma)
01/2014

Drug/Important Bio-Agent (IBA)

5ResveratrolIBA
05/2022 - 11/2016
5Pharmaceutical PreparationsIBA
01/2022 - 09/2012
3Hydroxyurea (Hydrea)FDA LinkGeneric
01/2018 - 04/2011
2CurcuminIBA
05/2022 - 11/2016
2Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2022 - 09/2012
2Histone Deacetylase InhibitorsIBA
01/2021 - 01/2020
2Fetal Hemoglobin (Hemoglobin F)IBA
01/2021 - 01/2018
2AntioxidantsIBA
12/2019 - 05/2014
2OxidesIBA
06/2018 - 01/2018
1Nitric Oxide Synthase (NO Synthase)IBA
01/2022
1Nitric Oxide DonorsIBA
01/2022
1pomalidomideIBA
01/2021
1GlobinsIBA
01/2021
1CarcinogensIBA
01/2020
1gamma-GlobinsIBA
01/2020
1Sunscreening Agents (Sunscreens)IBA
12/2019
1DipeptidesIBA
10/2019
1crisaboroleIBA
10/2019
1tavaboroleIBA
10/2019
1Boronic AcidsIBA
10/2019
1BoronIBA
10/2019
1Bortezomib (Velcade)FDA Link
10/2019
1ThiazolesIBA
01/2019
1SemicarbazonesIBA
01/2019
1ThiosemicarbazonesIBA
01/2019
1NifurtimoxIBA
07/2018
1benzonidazole (benznidazole)IBA
07/2018
1Cyclic N-Oxides (Oxides, Cyclic N)IBA
01/2018
1Therapeutic UsesIBA
11/2017
11,2,5-oxadiazole 2-oxideIBA
11/2016
1PolyphenolsIBA
11/2016
1Anti-Bacterial Agents (Antibiotics)IBA
10/2015
1Proton Pump InhibitorsIBA
10/2015
1PrimaquineFDA Link
01/2014
1ProdrugsIBA
01/2014
1EnzymesIBA
01/2014
1Chloroquine (Aralen)FDA LinkGeneric
01/2014
1Phe-Ala-PQIBA
01/2014
1phthalimideIBA
09/2012
1ethyl nitrateIBA
04/2011
1methyl nitrateIBA
04/2011
1NitratesIBA
04/2011
1BenzenesulfonamidesIBA
04/2011

Therapy/Procedure

6Therapeutics
05/2022 - 01/2018